Hudson Bay Capital Management’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-38,494
| Closed | -$3.17M | – | 803 |
|
|
2023
Q2 | $3.17M | Buy |
38,494
+25,494
| +196% | +$2.1M | 0.02% | 358 |
|
|
2023
Q1 | $1.34M | Buy |
13,000
+2,000
| +18% | +$206K | 0.01% | 525 |
|
|
2022
Q4 | $1.61M | Buy |
11,000
+1,200
| +12% | +$176K | 0.02% | 596 |
|
|
2022
Q3 | $1.66M | Sell |
9,800
-6,200
| -39% | -$1.05M | 0.01% | 741 |
|
|
2022
Q2 | $1.85M | Sell |
16,000
-1,400
| -8% | -$162K | 0.01% | 784 |
|
|
2022
Q1 | $1.74M | Buy |
17,400
+5,800
| +50% | +$579K | 0.02% | 717 |
|
|
2021
Q4 | $1.8M | Buy |
11,600
+4,600
| +66% | +$715K | 0.02% | 692 |
|
|
2021
Q3 | $1.65M | Buy |
7,000
+4,200
| +150% | +$990K | 0.02% | 652 |
|
|
2021
Q2 | $951K | Buy |
+2,800
| New | +$951K | 0.01% | 725 |
|